For shares of Aehr Test Systems NASDAQ: AEHR, it's hard to imagine a hotter start to 2026. As of the Jan. 20 close, the stock is already up 44% on the year.
Aehr Test Systems reported disappointing Q2/FY2026 results, with sales missing consensus expectations by approximately 15% and gross margins declining to new multi-year lows. While the company continued to burn cash, Aehr used the ongoing AI hype to replenish its dwindling cash balances by selling shares at elevated prices into the open market. On the conference call, management disclosed a slew of operational setbacks and order delays. As a result, H2/FY2026 results are expected to fall well short of consensus expectations.
Aehr Test Systems, Inc. (AEHR) Q2 2026 Earnings Call Transcript
Aehr Test Systems, Inc. (NASDAQ:AEHR ) Q1 2026 Earnings Call October 6, 2025 5:00 PM EDT Company Participants Gayn Erickson - President, CEO & Director Chris Siu - CFO, Executive VP of Finance & Secretary Conference Call Participants Jim Byers - PondelWilkinson Inc. Christian Schwab - Craig-Hallum Capital Group LLC, Research Division Mark Shooter - William Blair & Company L.L.C., Research Division Bradford Ferguson - Halter Ferguson Financial, Inc. Larry Chlebina - Chlebina Capital Management, LLC Presentation Operator Greetings.
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Aehr Test Systems, Inc.'s latest follow-on orders from its leading AI hyperscaler customer for Sonoma systems represent a significant validation to its technology. AEHR appears to be a key pillar to its hyperscaler customer's long-term plans due to the large-scale deployment of its Sonoma systems. AEHR's consumable BIM sales are likely to grow significantly as the hyperscaler customer intends to ramp production of their own AI processors and introduce new chip designs in CY 2026.
AEHR is a high-risk, high-reward binary play, with fiscal 2026 hugely important for the mid- to long-term investment case. The recent acquisition of Incal and AI processor exposure have repositioned Aehr from an 'EV loser' to a potential 'AI winner,' expanding its addressable market. Despite optimism, fundamentals remain weak: high valuation, margin pressure, and a history of failed growth spurts raise caution.
Shares in Aehr Test Systems (AEHR -3.26%) slumped by 22.2% in the first half of 2025, according to data provided by S&P Global Market Intelligence. That figure may surprise investors, not least because it's a long, long way from telling the whole story of a stock that declined 56% in the first three months of 2025 only to rise 77.4% in the last three months of the half-year.
Despite weak Q4 FY 2025 earnings, Aehr Test Systems has diversified its revenue streams and reduced its reliance on the SiC segment substantially, a promising sign for future growth. AEHR secured a major hyperscaler as its first AI customer and is demonstrating its systems with 2 more potential customers. Silicon photonics could be a large market for AEHR thanks to its relationship with an OSAT, potentially expanding its market reach indirectly.
Aehr Systems' Q4 results disappointed due to tariff uncertainty and sharp sales declines, especially in WaferPak, though packaged burn-in systems showed strength from AI demand. The company maintains a strong cash position with no debt, providing some cushion against ongoing volatility and negative sentiment in the market. Tariff risks and the end of US EV tax credits will likely prolong weakness in the EV segment, but AI-driven growth offers a promising offset.
Aehr Test Systems, Inc. (NASDAQ:AEHR ) Q4 2025 Earnings Conference Call July 8, 2025 5:00 PM ET Company Participants Chris P. Siu - CFO, Executive VP of Finance & Secretary Gayn Erickson - President, CEO & Director Conference Call Participants Christian David Schwab - Craig-Hallum Capital Group LLC, Research Division Jonathan Dorsheimer - William Blair & Company L.L.C.
Aehr Test Systems (AEHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.